Recommendations for the use of everolimus in de novo kidney transplantation: False beliefs, myths and realities

Recommendations for the use of everolimus in de novo kidney transplantation: False beliefs, myths and realities

The immunosuppressive combination most commonly used in de novo kidney transplantation comprises a calcineurin inhibitor (CI), tacrolimus, a mycophenolic acid derivative and steroids. The evidence which underlies this practice is based in the Symphony trial with controlled follow-up of one year, in...

Full description

Bibliographic Details
Main Authors: Julio Pascual, Fritz Diekmann, Constantino Fernández-Rivera, Gonzalo Gómez-Marqués, Alex Gutiérrez-Dalmau, María José Pérez-Sáez, Asunción Sancho-Calabuig, Federico Oppenheimer
Format: Article
Language:English
Published: Elsevier 2017-05-01
Series:Nefrología (English Edition)
Subjects:
Kidney transplant
Everolimus
mTOR inhibitors
Online Access:http://www.sciencedirect.com/science/article/pii/S2013251417300883

Internet

http://www.sciencedirect.com/science/article/pii/S2013251417300883

Similar Items